J 2014

Haematopoietic developmental potential of human pluripotent stem cell lines

TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL and Irena KRONTORÁD KOUTNÁ

Basic information

Original name

Haematopoietic developmental potential of human pluripotent stem cell lines

Authors

TESAŘOVÁ, Lenka (203 Czech Republic, belonging to the institution), Pavel ŠIMARA (203 Czech Republic, belonging to the institution), Stanislav STEJSKAL (203 Czech Republic, belonging to the institution) and Irena KRONTORÁD KOUTNÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Folia biologica, Praha, Univerzita Karlova, 2014, 0015-5500

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10601 Cell biology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.000

RIV identification code

RIV/00216224:14330/14:00073970

Organization unit

Faculty of Informatics

UT WoS

000343275800015

Keywords (in Czech)

lidské pluripotentní kmenové buňky; hematopoetický vývoj; embryoidní tělíska; CD34+ buňky

Keywords in English

human pluripotent stem cells; hematopoietic development; embryoid bodies; CD34+ cells

Tags

Změněno: 2/3/2018 10:06, Mgr. Pavel Šimara, Ph.D.

Abstract

V originále

The generation of hematopoietic progenitors from human pluripotent stem cells (hPSCs) presents great promise for cell-replacement therapies. However, current protocols for hematopoietic differentiation of hPSCs suffer from low efficiency and functional defects in the derived cells. The technology is also limited by variable ability of hPSC lines to generate blood cells in vitro. To address this issue, methodologies for hematopoietic differentiation in feeder-free conditions were applied to available human embryonic stem cell (hESC) and human induced pluripotent stem cell (hiPSC) lines in this study. It was found that these cell lines did not generate hematopoietic progenitors in such an extent as H1 and H9 hESC lines used for this purpose in the vast majority of relevant studies. These results suggest that for clinical application of blood cells derived from hPSCs, possibly from autologous hiPSCs, it is necessary to overcome the variability in the hematopoietic developmental potential of individual hPSC lines.

Links

CZ.1.07/2.3.00/30.0030, interní kód MU
Name: Rozvoj lidských zdrojů pro oblast buněčné biologie
Investor: Ministry of Education, Youth and Sports of the CR, 2.3 Human resources in research and development
GBP302/12/G157, research and development project
Name: Dynamika a organizace chromosomů během buněčného cyklu a při diferenciaci v normě a patologii
Investor: Czech Science Foundation